retatrutide clinical trials weight loss retatrutide If isn't FDA approved yet, how is everyone already taking it? 👀⁠ ⁠ On this episode of “The Beauty Authority,” board-certified endocrinologist @drrekhakumar explains why the next-generation weight-loss drug has become Retatrutide just delivered one of

Submit your standout campaign to the 2025 Pharmaceutical Executive APEX Awards and be celebrated among the best in pharma marketing

It seems unlikely that ITCA 650 will be able to tap into that fast-growing market anytime soon.

Rotating injection sites and allowing alcohol to dry completely before injection minimizes these reactions

Because this is an area with notable unmet needs, especially in terms of pharmacological treatment options, further research investment is warranted

documented the utility and current limitations of AOPs in regulatory risk assessment, noting that the framework supports hazard characterisation and integrated approaches to testing and assessment (IATA), but that quantitative response-response relationships remain underdeveloped (Bajard et al., 2022, DOI)

Update: In October 2024, ASA issued an Affirmation of Value for a more recent, multi-society guidance GLP-1 document